Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

NCT05116813 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated prior to completing enrollment goals due to COVID-related difficulties in recruiting patients

Conditions

Interventions

Sponsor

Addex Pharma S.A.